Skip to content
Peptides Codex

Use the arrow keys to choose a result, Enter to open it, and Escape to close.

← Home
Mitochondrial-derived peptide (MDP)

Humanin

Humanin is a mitochondrial-derived peptide encoded within the MT-RNR2 (16S rRNA) gene and was the first such peptide discovered.

By The Peptides Codex Editorial TeamIndividual review date not recorded

Page data last changed: . Chemistry registry snapshot: . Registry refreshes and identity assessments are separate from scientific content review.

Length
24 aa
Class
Mitochondrial-derived peptide (MDP)
Function
Studied as a cytoprotective signaling peptide
Context
Research peptide; not an approved drug in Canada

The first mitochondria-derived peptide discovered — a hub of longevity research.

Also known as: HN · MT-RNR2-derived peptide

Part of the Neuropeptides & signaling cluster

Overview

Humanin is a mitochondrial-derived peptide encoded within the MT-RNR2 (16S rRNA) gene and was the first such peptide discovered. It is studied as a cytoprotective signaling molecule in aging and neuroprotection research. It is not an approved therapeutic in Canada.

Source & context

Biological / chemical source: Encoded within the mitochondrial 16S rRNA gene (MT-RNR2)

Primary research or clinical context: Research peptide; not an approved drug in Canada

A mitochondrial messenger

Humanin is encoded inside the mitochondrial genome and is the founding member of the mitochondria-derived peptide (MDP) family, alongside compounds like MOTS-c. The cytosolic form is 24 residues (MAPRGFSCLLLLTSEIDLPVKRRA), while a shorter mitochondrially translated variant is about 21 residues.

Research directions

Laboratory studies have examined humanin in the context of cellular stress responses, neuroprotection, and metabolic signaling, which is why it appears frequently in longevity discussions. Most evidence is preclinical; human clinical data remain limited, so claims should be interpreted carefully.

Why it is searched

Interest in mitochondrial peptides and aging biology has pushed humanin into popular longevity content. This page summarizes its biology for educational purposes and does not provide dosing, protocols, or therapeutic recommendations.

Sequence

One-letter sequence commonly cited for Humanin (educational; isoforms and modifications may differ):

MAPRGFSCLLLLTSEIDLPVKRRA

MAPRGFSCLLLLTSEIDLPVKRRA

Humanin24 aa · C119H204N34O32S2 · ≈ 2,687.2 DaPEPTIDESCODEX.COMN-terminus →→ C-terminusM1A2P3R+4G5F6S7C8L9L10L11L12T13S14E−15I16D−17L18P19V20K+21R+22R+23A24nonpolarpolaracidicbasicGly / Pronon-canonical (X)Hydropathy (Kyte–Doolittle): ▮ hydrophobic (cyan) / ▮ hydrophilic (rose) · Side-chain charge at pH 7: + / −
Humanin — Structure cardDownload SVG
M1A2P3R4G5F6S7C8L9L10L11L12T13S14E15I16D17L18P19V20K21R22R23A24
Helical wheel projection

Residues plotted ~100° apart around an α-helix — clustering of one color reveals an amphipathic face.

Analyze sequences in the playground →

Structure & chemistry

Molecular identity & reference confidence

Source-supported reference

Reference values are taken from the cited molecular record or curated profile. A database match is not independent laboratory verification; modifications, counter-ions, and formulations can change the measured mass.

Molecular form
Humanin (source record; form not independently established)
Species
Not established by this molecular identity audit
Termini (N / C)
Not specified / Not specified

Average reference mass

Reference policy updated: 2026-10-05

Molecular formula
C119H204N34O32S2
Average reference mass
≈ 2,687.2
Identifiers

Chemistry values: PubChem, IUPHAR/BPS Guide to Pharmacology · fetched 2026-10-01.

Clinical development snapshot

ClinicalTrials.gov lists 3 registered studies with “Humanin” as an intervention (snapshot 2026-09-06). A registry footprint is not evidence of efficacy or approval.

Registered studies
3
Highest phase reached
Not applicable
Active in latest 100
1
Most recent update
2026-07-08
Most recently updated studies
NCTTitlePhaseStatusUpdated
NCT07678073Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, HumaniNot applicablerecruiting2026-07-08
NCT06105229Clinical Value of Plasma Humanin in Acute Kidney Injury—unknown2023-10-27
NCT03431844Humanin Isoforms in Cardiac Muscle and Blood Plasma and Major Complications After Cardiac Operation—completed2020-08-05
See all on ClinicalTrials.gov →
Concentration math

Humanin — reconstitution calculator

Enter how much peptide is in the vial and how much diluent (e.g. bacteriostatic water) is added. The tool returns the resulting solution concentration — and, for any amount you type, the volume it corresponds to. This is educational arithmetic, not a dosing recommendation.

Reference form: Humanin (source record; form not independently established)Average reference mass: 2,687.2 Da

Syringe graduation
Solution concentration
5 mg/mL5,000 mcg/mL
mcg

Enter an amount to see the volume it corresponds to.

Educational concentration mathematics only. This tool does not recommend a dose, amount, or protocol, and nothing here is medical advice. Many peptides are not authorized by Health Canada for human use — see our reconstitution and bacteriostatic-water guides for context.

Open the Humanin calculator on its own page →

FAQ about Humanin

What is Humanin?+

Humanin is a mitochondrial-derived peptide encoded within the MT-RNR2 (16S rRNA) gene and was the first such peptide discovered. It is studied as a cytoprotective signaling molecule in aging and neuroprotection research. It is not an approved therapeutic in Canada.

What Canadian product status is recorded for Humanin?+

Canadian product status for Humanin has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.

What is the typical length of Humanin?+

Humanin is commonly described as approximately 24 amino acids (Mitochondrial-derived peptide (MDP)).

Related peptides

References & further reading

  1. 1.Rochette (2020). Humanin: A mitochondria-derived peptide with emerging properties. Ann Cardiol Angeiol (Paris)
  2. 2.Maraux et al. (2025). HUMANIN produced by human efferocytic macrophages promotes the resolution of inflammation. Cell Death Dis
  3. 3.Hazafa et al. (2021). Humanin: A mitochondrial-derived peptide in the treatment of apoptosis-related diseases. Life Sci
  4. 4.Matsuoka et al. (2010). Humanin and the receptors for humanin. Mol Neurobiol
  5. 5.Zuccato et al. (2019). Mitochondrial-derived peptide humanin as therapeutic target in cancer and degenerative diseases. Expert Opin Ther Targets
  6. 6.Lue et al. (2021). The emerging role of mitochondrial derived peptide humanin in the testis. Biochim Biophys Acta Gen Subj
  7. 7.Lei et al. (2022). The role of humanin in the regulation of reproduction. Biochim Biophys Acta Gen Subj
  8. 8.Xiao et al. (2016). Humanin: Functional Interfaces with IGF-I. Growth Horm IGF Res
  9. 9.PubChem — compound summary for Humanin (CID 16131438)
  10. 10.Wikipedia — Humanin
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Humanin educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.